HMG (Human Menopausal Gonadotropin) — 75IU

Human Menopausal Gonadotropin (HMG) is a purified gonadotropin preparation containing both Follicle-Stimulating Hormone (FSH) and Luteinising Hormone (LH) in an approximately equal 1:1 ratio. Extracted from the urine of postmenopausal women, HMG provides a dual-gonadotropin research tool that closely mirrors the natural hormonal environment required for gonadal stimulation — making it a well-established reference compound in reproductive endocrinology and HPG axis research.

Mechanism of Interest
HMG delivers simultaneous FSH and LH activity, engaging both gonadotropin receptor pathways involved in gonadal function. FSH drives folliculogenesis and spermatogenesis, while LH supports steroidogenesis and triggers ovulation or Leydig cell testosterone production. This dual-receptor activity makes HMG uniquely suited to research models requiring combined gonadotropin stimulation, and a valuable comparator compound in studies examining the individual vs. combined contributions of FSH and LH to reproductive biology.

Research Focus Areas
• Dual FSH + LH receptor activity and gonadotropin signalling
• Folliculogenesis and ovarian stimulation models
• Spermatogenesis and male reproductive biology research
• Steroidogenesis and testosterone production pathways
• HPG axis regulation and gonadotropin feedback studies
• Comparative FSH vs. LH activity research
• Reproductive endocrinology and fertility biology

Specifications
• Total content: 75IU (FSH + LH, approximately 1:1 ratio)
• Form: Lyophilised powder
• Purity: Highly purified gonadotropin preparation
• Storage: 2–8°C, away from light and moisture

———

Important Notice

This product is supplied strictly for laboratory research use only. It is not intended for human or veterinary use.

By purchasing, the buyer confirms they are a qualified professional or acting on behalf of a licensed research facility and accept full responsibility for safe handling, storage, and use in accordance with all applicable guidelines. No claims are made regarding the safety or effectiveness of this compound outside of a controlled research environment.